CYTARABINE and PNEUMONIA

Overview

PNEUMONIA is the #9 most commonly reported adverse reaction for CYTARABINE, manufactured by Fresenius Kabi USA, LLC. There are 2,258 FDA adverse event reports linking CYTARABINE to PNEUMONIA. This represents approximately 2.1% of all 108,092 adverse event reports for this drug.

Patients taking CYTARABINE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PNEUMONIA is a less commonly reported adverse event for CYTARABINE, but still significant enough to appear in the safety profile.

Other Side Effects of CYTARABINE

In addition to pneumonia, the following adverse reactions have been reported for CYTARABINE:

• FEBRILE NEUTROPENIA — 7,376 reports
• OFF LABEL USE — 4,870 reports
• PYREXIA — 4,012 reports
• NEUTROPENIA — 3,559 reports
• DRUG INEFFECTIVE — 3,063 reports
• SEPSIS — 2,897 reports
• THROMBOCYTOPENIA — 2,835 reports
• DISEASE PROGRESSION — 2,693 reports
• PANCYTOPENIA — 2,055 reports
• DEATH — 1,995 reports

Other Drugs Associated with PNEUMONIA

The following drugs have also been linked to pneumonia in FDA adverse event reports:

Does CYTARABINE cause PNEUMONIA?

PNEUMONIA has been reported as an adverse event in 2,258 FDA reports for CYTARABINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PNEUMONIA with CYTARABINE?

PNEUMONIA accounts for approximately 2.1% of all adverse event reports for CYTARABINE, making it a notable side effect.

What should I do if I experience PNEUMONIA while taking CYTARABINE?

If you experience pneumonia while taking CYTARABINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages